Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 4, Issue 11, Pages 1659-1666
Publisher
Wiley
Online
2015-08-27
DOI
10.1002/cam4.514
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer
- (2017) Emil Lou et al. Cancer Biomarkers
- Effect of 3 to 5 Years of Scheduled CEA and CT Follow-up to Detect Recurrence of Colorectal Cancer
- (2014) John N. Primrose et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Esophageal Cancer Management: Preoperative CA19.9 and CEA Serum Levels May Identify Occult Advanced Adenocarcinoma
- (2014) Marco Scarpa et al. WORLD JOURNAL OF SURGERY
- Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial
- (2013) M. A. Gordon et al. ANNALS OF ONCOLOGY
- Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
- (2012) A. F. C. Okines et al. ANNALS OF ONCOLOGY
- Adverse Prognostic Impact of Intratumor Heterogeneous HER2 Gene Amplification in Patients With Esophageal Adenocarcinoma
- (2012) Harry H. Yoon et al. JOURNAL OF CLINICAL ONCOLOGY
- uPAR as Anti-Cancer Target: Evaluation of Biomarker Potential, Histological Localization, and Antibody-Based Therapy
- (2011) Ida K. Lund et al. CURRENT DRUG TARGETS
- Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients
- (2011) M. Łukaszewicz-Zając et al. DISEASES OF THE ESOPHAGUS
- Prognosis in adenocarcinomas of lower oesophagus, gastro-oesophageal junction and cardia evaluated by uPAR-immunohistochemistry
- (2011) Ole Didrik Laerum et al. INTERNATIONAL JOURNAL OF CANCER
- C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management
- (2011) Pragatheeshwar Thirunavukarasu et al. JNCI-Journal of the National Cancer Institute
- Carcinoembryonic antigen (CEA) as tumor marker in lung cancer
- (2011) M. Grunnet et al. LUNG CANCER
- Cancer and Inflammation: Promise for Biologic Therapy
- (2010) Sandra Demaria et al. JOURNAL OF IMMUNOTHERAPY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
- (2009) Li-Chu Sun et al. BMC CANCER
- Prognostic Role of KRAS and BRAF in Stage II and III Resected Colon Cancer: Results of the Translational Study on the PETACC-3, EORTC 40993, SAKK 60-00 Trial
- (2009) Arnaud D. Roth et al. JOURNAL OF CLINICAL ONCOLOGY
- Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan
- (2008) Chika Kusano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and Age
- (2008) L. M. Brown et al. JNCI-Journal of the National Cancer Institute
- The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients
- (2007) Barbara Mroczko et al. CLINICA CHIMICA ACTA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now